A detailed history of Cwm, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Cwm, LLC holds 100 shares of LUNG stock, worth $828. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 64 56.25%
Holding current value
$828
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$5.77 - $9.82 $207 - $353
36 Added 56.25%
100 $1,000
Q1 2024

Apr 05, 2024

SELL
$8.71 - $14.65 $60 - $102
-7 Reduced 9.86%
64 $1,000
Q4 2023

Feb 01, 2024

BUY
$7.89 - $13.14 $157 - $262
20 Added 39.22%
71 $1,000
Q4 2022

Feb 01, 2023

BUY
$4.92 - $17.35 $206 - $728
42 Added 466.67%
51 $0
Q2 2022

Jul 28, 2022

BUY
$14.0 - $27.95 $126 - $251
9 New
9 $0
Q1 2022

Apr 21, 2022

SELL
$21.13 - $35.65 $105 - $178
-5 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$29.72 - $45.1 $148 - $225
5 New
5 $0

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.